Abstract
Osseous sarcoidosis is relatively uncommon, and treatment with corticosteroids is not always effective. Moreover, patients with an advanced stage of pulmonary sarcoidosis are sometimes infected with aspergillus in the cavities of the pulmonary lesions, and long-term use of corticosteroids should be prohibited to prevent the development of fatal invasive pulmonary aspergillosis. Here, we described a unique case of osseous sarcoidosis with pulmonary aspergillosis, showing a rapid improvement of the osseous symptoms just after the administration of the antifungal agent, itraconazole. Itraconazole is likely to become a candidate among new therapeutic agents for osseous sarcoidosis.
Original language | English |
---|---|
Pages (from-to) | 75-78 |
Number of pages | 4 |
Journal | Sarcoidosis Vasculitis and Diffuse Lung Diseases |
Volume | 28 |
Issue number | 1 |
Publication status | Published - 2011 |
Keywords
- Aspergillosis
- Bone sarcoidosis
- Corticosteroids
- Itraconazole
ASJC Scopus subject areas
- Internal Medicine
- Immunology and Allergy
- Pulmonary and Respiratory Medicine